{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:46:48Z","timestamp":1781304408905,"version":"3.54.1"},"reference-count":139,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.rdc.2014.04.006","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T03:45:29Z","timestamp":1405395929000},"page":"455-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The Immunopathology of Cutaneous Lupus Erythematosus"],"prefix":"10.1016","volume":"40","author":[{"given":"Mark G.","family":"Kirchhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Dutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.rdc.2014.04.006_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1191\/0961203304lu2020oa","article-title":"Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus","volume":"13","author":"Albrecht","year":"2004","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.rdc.2014.04.006_bib2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2014.04.006_bib3","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archdermatol.2009.21","article-title":"Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study","volume":"145","author":"Durosaro","year":"2009","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gronhagen","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaad.2013.02.010","article-title":"Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus","volume":"69","author":"Merola","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2014.04.006_bib7","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/ar2887","article-title":"Use of type I interferon-inducible mRNAs as\u00a0pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFN\u03b1 antibody, in systemic lupus erythematosus","volume":"12","author":"Yao","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0889-857X(05)70137-X","article-title":"Genetics of systemic lupus erythematosus. Clinical implications","volume":"26","author":"Sullivan","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib9","doi-asserted-by":"crossref","first-page":"e1001311","DOI":"10.1371\/journal.pgen.1001311","article-title":"Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes","volume":"7","author":"Taylor","year":"2011","journal-title":"PLoS Genet"},{"issue":"9","key":"10.1016\/j.rdc.2014.04.006_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11926-013-0369-4","article-title":"Genetics and epigenetics of systemic lupus erythematosus","volume":"15","author":"Costa-Reis","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2014.04.006_bib11","article-title":"The role of genetic variation near interferon-kappa in systemic lupus erythematosus","volume":"2010","author":"Harley","year":"2010","journal-title":"J\u00a0Biomed Biotechnol"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0625.2009.00982.x","article-title":"Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus","volume":"19","author":"Jarvinen","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.rdc.2014.04.006_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-013-8403-x","article-title":"Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review","author":"Kuhn","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib14","first-page":"13","article-title":"UV-A irradiation induces transcription of IL-6 and TNF alpha genes in human keratinocytes and dermal fibroblasts","volume":"66","author":"Avalos-Diaz","year":"1999","journal-title":"Rev Rhum Engl Ed"},{"issue":"14","key":"10.1016\/j.rdc.2014.04.006_bib15","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1073\/pnas.96.14.7974","article-title":"Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation","volume":"96","author":"Kulms","year":"1999","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/PL00000209","article-title":"Comparative quantification of IL-1beta, IL-10, IL-10r, TNF alpha and IL-7 mRNA levels in UV-irradiated human skin in\u00a0vivo","volume":"49","author":"Brink","year":"2000","journal-title":"Inflamm Res"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib17","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/jid.2008.332","article-title":"UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription","volume":"129","author":"Bashir","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2133.1994.tb08516.x","article-title":"Ultraviolet-A radiation induces adhesion molecule expression on human dermal microvascular endothelial cells","volume":"131","author":"Heckmann","year":"1994","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/096120339700600213","article-title":"Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE","volume":"6","author":"Casciola-Rosen","year":"1997","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.rdc.2014.04.006_bib20","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/jid.2008.453","article-title":"High Ro52 expression in spontaneous and UV-induced cutaneous inflammation","volume":"129","author":"Oke","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus\u00a0erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.immuni.2013.08.004","article-title":"Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing","volume":"39","author":"Gehrke","year":"2013","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1365-2133.2002.04627.x","article-title":"Systemic lupus erythematosus induced by Epstein-Barr virus infection","volume":"146","author":"Verdolini","year":"2002","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.rdc.2014.04.006_bib24","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry","volume":"11","author":"McClain","year":"2005","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.rdc.2014.04.006_bib26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","article-title":"Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases","volume":"24","author":"Pender","year":"2003","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/096120339500400511","article-title":"Cytomegalovirus infection induces expression of 60 KD\/Ro antigen on human keratinocytes","volume":"4","author":"Zhu","year":"1995","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/RHU.0b013e3181775e80","article-title":"Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C","volume":"14","author":"Ho","year":"2008","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1600-0560.2012.01894.x","article-title":"Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists","volume":"39","author":"Hawryluk","year":"2012","journal-title":"J\u00a0Cutan Pathol"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","article-title":"Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions","volume":"143","author":"de Gannes","year":"2007","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib31","first-page":"465","article-title":"A\u00a0systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden","volume":"167","author":"Gronhagen","year":"2012","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.rdc.2014.04.006_bib33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/rheumatology\/kel094","article-title":"Association between cigarette smoking and release of tumour necrosis factor alpha and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis","volume":"45","author":"Glossop","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.rdc.2014.04.006_bib34","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/jid.2011.237","article-title":"Cigarette smoking and response to antimalarials in cutaneous lupus erythematosus patients: evolution of a dogma","volume":"131","author":"Dutz","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"12","key":"10.1016\/j.rdc.2014.04.006_bib35","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1172\/JCI0214873","article-title":"Estrogen alters thresholds for B cell apoptosis and activation","volume":"109","author":"Grimaldi","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.rdc.2014.04.006_bib36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1191\/0961203304lu1094oa","article-title":"Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity","volume":"13","author":"Cutolo","year":"2004","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/000155598442692","article-title":"Estrogenic xenobiotics increase expression of SS-A\/Ro autoantigens in cultured human epidermal cells","volume":"78","author":"Sakabe","year":"1998","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib38","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/art.21658","article-title":"Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation","volume":"54","author":"Kuhn","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib39","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1084\/jem.185.5.843","article-title":"Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus","volume":"185","author":"Utz","year":"1997","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.autrev.2008.07.015","article-title":"Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE)","volume":"8","author":"Janko","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib41","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.4049\/jimmunol.176.4.2074","article-title":"Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN","volume":"176","author":"Le Bon","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"12","key":"10.1016\/j.rdc.2014.04.006_bib42","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2004.033753","article-title":"Type I interferon correlates with serological and clinical manifestations of SLE","volume":"64","author":"Dall'era","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.rdc.2014.04.006_bib43","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1084\/jem.194.12.f59","article-title":"A\u00a0pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus","volume":"194","author":"Ronnblom","year":"2001","journal-title":"J\u00a0Exp Med"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib44","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/art.20254","article-title":"Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG","volume":"50","author":"Lovgren","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","article-title":"Plasmacytoid dendritic cells (natural interferon- alpha\/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions","volume":"159","author":"Farkas","year":"2001","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2133.2012.10825.x","article-title":"The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score","volume":"166","author":"Braunstein","year":"2012","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib47","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jaad.2006.08.014","article-title":"CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus","volume":"56","author":"Wenzel","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib48","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1365-2133.2011.10479.x","article-title":"Interferon-alpha stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus","volume":"165","author":"Zahn","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/jid.2010.244","article-title":"Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNlambda) in cutaneous lupus erythematosus","volume":"131","author":"Zahn","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"7454","key":"10.1016\/j.rdc.2014.04.006_bib50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature12305","article-title":"Structural mechanism of cytosolic DNA sensing by cGAS","volume":"498","author":"Civril","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2011.11.018","article-title":"Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease","volume":"36","author":"Gall","year":"2012","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib52","first-page":"375","article-title":"Association of interferon\u00a0gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity","volume":"46","author":"Robak","year":"1998","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/jid.2013.269","article-title":"Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis","volume":"134","author":"Jabbari","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00403-008-0893-7","article-title":"TNF-alpha production in the skin","volume":"301","author":"Bashir","year":"2009","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"10.1016\/j.rdc.2014.04.006_bib55","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/art.23868","article-title":"Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus","volume":"58","author":"Wang","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.2005.039362","article-title":"Tumour necrosis factor alpha is expressed in refractory skin lesions from patients with subacute cutaneous lupus erythematosus","volume":"65","author":"Zampieri","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib57","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1523-1747.2000.00118.x","article-title":"Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription","volume":"115","author":"Werth","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"issue":"11","key":"10.1016\/j.rdc.2014.04.006_bib58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0025-6196(11)60668-X","article-title":"Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic","volume":"84","author":"Wetter","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"5425","key":"10.1016\/j.rdc.2014.04.006_bib59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","article-title":"BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator","volume":"285","author":"Moore","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jdermsci.2013.11.007","article-title":"Differential expression of BAFF and its receptors in discoid lupus erythematosus patients","volume":"73","author":"Chong","year":"2014","journal-title":"J\u00a0Dermatol Sci"},{"issue":"8","key":"10.1016\/j.rdc.2014.04.006_bib61","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.20062567","article-title":"BAFF and MyD88 signals promote a lupus like disease independent of T cells","volume":"204","author":"Groom","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"Pt 1","key":"10.1016\/j.rdc.2014.04.006_bib62","first-page":"1","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.147.1.117","article-title":"Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis","volume":"147","author":"Linker-Israeli","year":"1991","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s100670050045","article-title":"Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus","volume":"18","author":"Davas","year":"1999","journal-title":"Clin Rheumatol"},{"issue":"48","key":"10.1016\/j.rdc.2014.04.006_bib65","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1073\/pnas.0910371106","article-title":"Epidermal loss of JunB leads to a SLE\u00a0phenotype due to hyper IL-6 signaling","volume":"106","author":"Pflegerl","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib66","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/ard.62.1.37","article-title":"Immune complexes from SLE sera induce\u00a0IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE","volume":"62","author":"Ronnelid","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.rdc.2014.04.006_bib68","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2","article-title":"Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus","volume":"43","author":"Llorente","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2014.04.006_bib69","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib70","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24499","article-title":"Th17 and natural Treg cell population dynamics in\u00a0systemic lupus erythematosus","volume":"60","author":"Yang","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib71","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejim.2010.03.004","article-title":"IL-17 in cutaneous lupus erythematosus","volume":"21","author":"Tanasescu","year":"2010","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib72","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.21034","article-title":"Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus","volume":"52","author":"Meller","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib73","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J\u00a0Pathol"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib74","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","article-title":"Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation","volume":"194","author":"Flier","year":"2001","journal-title":"J\u00a0Pathol"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib75","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2133.2007.08137.x","article-title":"The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets","volume":"157","author":"Wenzel","year":"2007","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib76","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.22699","article-title":"Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus","volume":"56","author":"Franz","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib77","doi-asserted-by":"crossref","first-page":"e5776","DOI":"10.1371\/journal.pone.0005776","article-title":"Phenotypic characterization of autoreactive B cells\u2013checkpoints of B cell tolerance in patients with systemic lupus erythematosus","volume":"4","author":"Jacobi","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib78","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib79","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1600-0560.2009.01443.x","article-title":"The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis","volume":"37","author":"Magro","year":"2010","journal-title":"J\u00a0Cutan Pathol"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2014.04.006_bib80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-007-0031-x","article-title":"Pathophysiology of cutaneous lupus erythematosus","volume":"33","author":"Lin","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib81","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-97-5-664","article-title":"Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus","volume":"97","author":"Sontheimer","year":"1982","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.rdc.2014.04.006_bib82","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/08916930701510673","article-title":"Complement deficiencies and systemic lupus erythematosus","volume":"40","author":"Truedsson","year":"2007","journal-title":"Autoimmunity"},{"issue":"10","key":"10.1016\/j.rdc.2014.04.006_bib83","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.158.10.4525","article-title":"C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited","volume":"158","author":"Korb","year":"1997","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.rdc.2014.04.006_bib84","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/art.24852","article-title":"C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis","volume":"60","author":"Lood","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2\u20133","key":"10.1016\/j.rdc.2014.04.006_bib85","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaut.2007.02.005","article-title":"Clearance deficiency and systemic lupus erythematosus (SLE)","volume":"28","author":"Gaipl","year":"2007","journal-title":"J\u00a0Autoimmun"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib86","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.immuni.2010.11.025","article-title":"Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage","volume":"33","author":"Teichmann","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.rdc.2014.04.006_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2012.07.005","article-title":"Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus","volume":"40","author":"Hansel","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib88","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1684\/ejd.2013.1970","article-title":"Pathogenic CCR6+ dendritic cells in the skin lesions of discoid lupus patients: a role for damage-associated molecular patterns","volume":"23","author":"Mendez-Reguera","year":"2013","journal-title":"Eur J Dermatol"},{"issue":"5663","key":"10.1016\/j.rdc.2014.04.006_bib89","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib90","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar4264","article-title":"Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus","volume":"15","author":"Leffler","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"73","key":"10.1016\/j.rdc.2014.04.006_bib91","doi-asserted-by":"crossref","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci Transl Med"},{"issue":"13","key":"10.1016\/j.rdc.2014.04.006_bib92","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1084\/jem.20101048","article-title":"Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9","volume":"207","author":"Guiducci","year":"2010","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib93","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.rdc.2014.04.006_bib94","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.rdc.2014.04.006_bib95","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1002\/eji.200737815","article-title":"Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms","volume":"37","author":"Barrat","year":"2007","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib96","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2010.06.018","article-title":"Cutaneous lupus erythematosus: update of therapeutic options part I","volume":"65","author":"Kuhn","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.rdc.2014.04.006_bib97","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2012.10.005","article-title":"Therapeutic strategies evaluated by the\u00a0European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus","volume":"12","author":"Sigges","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.rdc.2014.04.006_bib98","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/cdd.2013.82","article-title":"Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids","volume":"20","author":"Lauber","year":"2013","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib99","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1468-3083.2011.04161.x","article-title":"Effectiveness of topical calcineurin inhibitors as monotherapy or in combination with hydroxychloroquine in cutaneous lupus erythematosus","volume":"26","author":"Avgerinou","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.rdc.2014.04.006_bib100","first-page":"933","article-title":"A\u00a0comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index","volume":"95","author":"Pothinamthong","year":"2012","journal-title":"J\u00a0Med Assoc Thai"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib101","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib102","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archdermatol.2011.2558","article-title":"Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study","volume":"148","author":"Frances","year":"2012","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.rdc.2014.04.006_bib103","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archdermatol.2011.191","article-title":"Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis","volume":"147","author":"Chang","year":"2011","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.rdc.2014.04.006_bib104","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines","volume":"186","author":"Kuznik","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib105","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib106","first-page":"1124","article-title":"The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus","volume":"159","author":"Wozniacka","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib107","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1529-8019.2012.01508.x","article-title":"Cutaneous lupus erythematosus","volume":"25","author":"Hansen","year":"2012","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib108","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archdermatol.2008.594","article-title":"Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients","volume":"145","author":"Moghadam-Kia","year":"2009","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib109","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1023\/B:JOCI.0000029107.47085.1b","article-title":"Systemic treatment with either cyclosporin A or methotrexate does not influence the T helper 1\/T helper 2 balance in psoriatic patients","volume":"24","author":"Rentenaar","year":"2004","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2230.2011.04188.x","article-title":"Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions","volume":"37","author":"Hornung","year":"2012","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib111","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2133.2011.10693.x","article-title":"Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome","volume":"166","author":"Cortes-Hernandez","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib112","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1186\/ar4111","article-title":"Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus","volume":"14","author":"Cortes-Hernandez","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.rdc.2014.04.006_bib113","first-page":"1224","article-title":"Apremilast for discoid lupus erythematosus: results of a phase 2, open-label, single-arm, pilot study","volume":"11","author":"De Souza","year":"2012","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"12","key":"10.1016\/j.rdc.2014.04.006_bib114","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","article-title":"Apremilast mechanism of action and application to psoriasis and psoriatic arthritis","volume":"83","author":"Schafer","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.1992.tb14851.x","article-title":"Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine","volume":"127","author":"Ruzicka","year":"1992","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib116","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/archderm.1986.01660140060018","article-title":"Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus","volume":"122","author":"Newton","year":"1986","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib117","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.jaad.2011.10.030","article-title":"Alitretinoin for cutaneous lupus erythematosus","volume":"67","author":"Kuhn","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib118","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2133.2012.10949.x","article-title":"Immunoregulatory effects of isotretinoin in patients with acne","volume":"167","author":"Karadag","year":"2012","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.rdc.2014.04.006_bib119","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1346-8138.2012.01637.x","article-title":"Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris","volume":"39","author":"Niu","year":"2012","journal-title":"J\u00a0Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2014.04.006_bib120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/120347541201600620","article-title":"Hypertrophic and ulcerated discoid lupus erythematosus","volume":"16","author":"Green","year":"2012","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.rdc.2014.04.006_bib121","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2340\/00015555-1467","article-title":"Ustekinumab in the treatment of refractory chronic cutaneous lupus erythematosus: a case report","volume":"93","author":"Dahl","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/j.rdc.2014.04.006_bib122","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archdermatol.2011.185","article-title":"Successful treatment of subacute lupus erythematosus with ustekinumab","volume":"147","author":"De Souza","year":"2011","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.rdc.2014.04.006_bib123","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1177\/0961203311409963","article-title":"Possible role of the JAK\/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus","volume":"20","author":"Kawasaki","year":"2011","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.rdc.2014.04.006_bib124","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/jid.2011.140","article-title":"Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation","volume":"131","author":"Fridman","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/exd.12265","article-title":"Jackpot! new small molecules in autoimmune and inflammatory diseases","volume":"23","author":"Ghoreschi","year":"2014","journal-title":"Exp Dermatol"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2014.04.006_bib126","first-page":"S683","article-title":"AMG 811 (anti-IFN-gamma) treatment leads to a reduction in the whole blood IFN-signature and serum CXCL10 in subjects with systemic lupus erythematosus, 2013 systemic lupus erythematosus: results of two phase I studies","volume":"65","author":"Martin","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2014.04.006_bib127","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/0961203313497115","article-title":"Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus\u2013report of 17 cases and review of the literature","volume":"22","author":"Hofmann","year":"2013","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.rdc.2014.04.006_bib128","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1002\/art.34564","article-title":"Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus","volume":"64","author":"Merrill","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib129","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archdermatol.2010.435","article-title":"Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus","volume":"147","author":"Klein","year":"2011","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2014.04.006_bib130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/RHU.0b013e31823ecd73","article-title":"Successful use of interleukin 6 antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis","volume":"18","author":"Makol","year":"2012","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2014.04.006_bib131","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1002\/art.38091","article-title":"Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus","volume":"65","author":"Szepietowski","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2014.04.006_bib132","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/ard.2010.144485","article-title":"Safety profile and clinical activity of sifalimumab, a fully human anti-interferon alpha monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study","volume":"70","author":"Merrill","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2014.04.006_bib133","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/art.37824","article-title":"Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study","volume":"65","author":"Petri","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2014.04.006_bib134","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/0961203309106921","article-title":"Intravenous immunoglobulins in\u00a0systemic lupus erythematosus: from the bench to the bedside","volume":"18","author":"Zandman-Goddard","year":"2009","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.rdc.2014.04.006_bib135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0961203309355299","article-title":"Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL\/lpr mouse model of systemic lupus","volume":"19","author":"Racz","year":"2010","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib136","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/09546630310018789","article-title":"Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE)","volume":"15","author":"Goodfield","year":"2004","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"2\u20133","key":"10.1016\/j.rdc.2014.04.006_bib137","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12016-009-8162-x","article-title":"Intravenous immunoglobulin in lupus panniculitis","volume":"38","author":"Espirito Santo","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"10.1016\/j.rdc.2014.04.006_bib138","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/art.38082","article-title":"Contrasting mechanisms of interferon-alpha inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists","volume":"65","author":"Wiedeman","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2014.04.006_bib139","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-010-9469-3","article-title":"IVIg attenuates TLR-9 activation in B cells from SLE patients","volume":"31","author":"Kessel","year":"2011","journal-title":"J\u00a0Clin Immunol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X14000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X14000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:23Z","timestamp":1760181203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X14000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0889857X14000416"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2014.04.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Immunopathology of Cutaneous Lupus Erythematosus","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2014.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}